Hydralazine Hydrochloride Tablet, Film Coated
Product Images NDC 63187-901

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 63187-901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

A9cb621b-figure-01 (A9cb621b Figure 01)

A9cb621b-figure-01 (A9cb621b Figure 01)
Not available. This is not a readable text, it is only an ampersand symbol.*
FDA Label Image

63187-901-30 (A9cb621b Figure 03)

63187-901-30 (A9cb621b Figure 03)
This is a description of a medication named "Hydralazine HCI 25mg" manufactured by Heritage Pharmaceuticals Inc. The medication is in tablet form and each tablet contains 25 mg of Hydralazine Hydrochloride. The tablets are pink in color and come in a pack of 90 tablets. It is RX only medication and should be stored at temperatures between 20°C to 25°C (68°F to 77°F) and kept out of reach of children. The lot number of the pack is 00000.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.